Literature DB >> 29081342

Role of Diabetes Mellitus on Treatment Effects in Drug-susceptible Initial Pulmonary Tuberculosis Patients in China.

Yan Ma1, Mai Ling Huang1, Tao Li2, Jian DU1, Wei Shu1, Shi Heng Xie1, Hong Hong Wang1, Guo Feng Zhu3, Shou Yong Tan4, Yan Yong Fu5, Li Ping Ma6, Lian Ying Zhang7, Fei Ying Liu8, Dai Yu Hu9, Yan Ling Zhang10, Xiang Qun Li3, Yu Hong Liu1, Liang Li1.   

Abstract

We assessed the role of diabetes mellitus (DM) on treatment effects in drug-susceptible initial pulmonary tuberculosis (PTB) patients. A prospective study was conducted in eight provinces of China from October 2008 to December 2010. We enrolled 1,313 confirmed drug-susceptible initial PTB patients, and all subjects received the treatment regimen (2H3R3E3Z3/4H3R3) as recommended by the national guidelines. Of the 1,313 PTB patients, 157 (11.9%) had DM; these patients had more sputum smear-positive rates at the end of the second month [adjusted odds ratios (aOR) 2.829, 95% confidence intervals (CI) 1.783-4.490], and higher treatment failure (aOR 2.120, 95% CI 1.565-3.477) and death rates (aOR 1.536, 95% CI 1.011-2.628). DM was a contributing factor for culture-positive rates at the end of the second month and treatment failure and death of PTB patients, thus playing an unfavorable role in treatment effects of PTB.
Copyright © 2017 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Treatment outcome; Tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 29081342     DOI: 10.3967/bes2017.089

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  3 in total

1.  Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up.

Authors:  Y Ma; Y Pang; W Shu; Y-H Liu; Q-P Ge; J Du; L Li; W-W Gao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-20       Impact factor: 3.267

2.  Diabetes mellitus among adults with tuberculosis in the USA, 2010-2017.

Authors:  Lori R Armstrong; J Steve Kammerer; Maryam B Haddad
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

3.  Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study.

Authors:  Anna Cristina C Carvalho; Gustavo Amorim; Mayla G M Melo; Ana Karla A Silveira; Pedro H L Vargas; Adriana S R Moreira; Michael S Rocha; Alexandra B Souza; María B Arriaga; Mariana Araújo-Pereira; Marina C Figueiredo; Betina Durovni; José R Lapa-E-Silva; Solange Cavalcante; Valeria C Rolla; Timothy R Sterling; Marcelo Cordeiro-Santos; Bruno B Andrade; Elisangela C Silva; Afrânio L Kritski
Journal:  Front Immunol       Date:  2021-07-02       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.